LMNB2 expression was significantly associated with the molecular subtype of ACC, BRCA, colon adenocarcinoma (COAD), esophageal carcinoma (ESCA), glioblastoma multiforme (GBM), KIRP, head and neck squamous cell carcinoma (HNSC), LGG, lung squamous cell carcinoma (LUSC), LIHC, ovarian Serous cystadenocarcinoma (OV), PCPG, STAD and uterine corpus endometrial carcinoma (UCEC) (Supplementary Figure 1). Here, LMNB2 is linked to ovarian serous cystadenocarcinoma.